Podcasts about potential role

Peter Schiff critiques 'Presidents' Day,' markets, inflation, economic data, gold, silver, and government's fiscal mismanagement.Put together your best look yet at https://indochino.com. Use code GOLD for 20% off orders of $499 or more.Peter Schiff opens the episode by discussing the misnomer of 'President's Day' and advocating for the correct recognition of Washington's Birthday. He explains the holiday's legal history and criticizes the commercialization of the day. Peter then transitions to recent economic data, including higher-than-expected producer and consumer price inflation (PPI and CPI) and disappointing retail sales. He argues that these numbers indicate rising inflation contrary to the Federal Reserve's targets. Schiff delves into recent gold and silver market movements, attributing fluctuations to economic reports and trader behavior. He advises listeners on investment strategies, emphasizing the purchase of physical metals ahead of potential tariffs. He also critiques U.S. government spending, highlighting surging interest payments on national debt and advocating for significant fiscal reforms, including reducing military expenditures and balancing the budget through substantial cuts. Schiff stresses the need for a shift from a consumption-based economy to a production-based one, suggesting that President Trump could enforce these changes by refusing to sign any debt ceiling increases.

- Introduction and Overview of Brighton.com (0:00) - AI Tools and Prompt Engineering (5:48) - Introduction to Enoch AI Tool (15:10) - Special Report on California's Failed State Status (21:29) - Interview with Andy Schlafly on Corporate Transparency Act (41:24) - Conclusion and Call to Action (41:44) - Government's Actions and Legal Challenges (1:09:54) - Supreme Court Involvement and Justice Alito (1:31:15) - Deep State and Selective Prosecution (1:35:00) - Support for AAPs and Medical Freedom (2:00:50) - Impact on Small Businesses and Volunteer Organizations (2:07:44) - Trump's Potential Role and Executive Orders (2:08:00) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Featuring perspectives from Dr Alexander Perl, Dr Eytan M Stein, Dr Richard M Stone, Dr Eunice S Wang and Prof Andrew H Wei, moderated by Dr Stein, including the following topics: Introduction (0:00) Treatment for Older Patients with Acute Myeloid Leukemia (AML) — Prof Wei (2:48) Selection of Initial Therapy for Younger Patients with AML without a Targetable Mutation, Including Those with Secondary AML — Dr Stone (26:52) Role of FLT3 Inhibitors in AML Management — Dr Perl (49:41) Incorporation of IDH Inhibitors into the Care of Patients with AML — Dr Stein (1:13:57) Potential Role of Menin Inhibitors and Other Novel Agents in the Treatment of AML — Dr Wang (1:35:50) CME information and select publications

PART ONE: After Jaxson Hayes caught a DNP-CD against the Cavs, Anthony had an educated theory he was wondering about pretty much confirmed. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

LISTEN | LEARNWhat's up rockstar!I'm interrupting our regular broadcast to change the tune to inform you of our near future financial transition to a decentralized and SOUND MONEY ecosystem. Giving a shout out to my friend Jake Claver, and the Beyond Broke Mastermind - where pioneers see the largest transfer of wealth - well on it's way. So in light of this, I made a conversational interview to share the potential fall of Bitcoin and the rise of XRP digital assets. PS. OUR FUTURE IS BRIGHT. Let's jump in! Global Financial Domino Effect: From Japan to Bitcoin & XRPIn this episode I propose a audio version from the awesome Jake Claver (Beyond Broke) on the compelling theory where economic changes in Japan could set off a chain reaction impacting Bitcoin, the U.S. stock market, and surprisingly, XRP. BREAKDOWN: 00:00 Introduction to the Global Financial Scenario00:50 Understanding the Yen Carry Trade01:30 Potential Disruptions and Their Impact02:55 Bitcoin and the Crypto Market Reaction04:08 The Role of Stablecoins and Regulations05:16 XRP's Potential Role in the Financial Ecosystem08:20 Implications for the U.S. Stock Market11:36 Lessons for Individual Investors14:22 Conclusion and Key TakeawaysIn addition, dropping a incredible book for those new to our future wealth ecosystem by Linda Jones!Her book supports women, and brining them up to speed on wealth management. inda P. Jones, America's Wealth MentorTM, has written this book in a way that is simple to understand and easy to implement. You will learn how to shave decades off the time it takes for investing success by potentially earning some of the highest compounding rates ever in history.Adding just 5% of cryptocurrency investments to your portfolio can create life-changing wealth. You can reach financial freedom, early retirement, or generate your next millions. Millionaires have already been created out of small investors, some with less than $1,000 invested.You will gain financial confidence while learning:* Why new technological revolution is creating a trillions of dollars of value* Which cryptocurrencies will be the dominant technologies that will generate wealth* Why this is the best investing opportunity in our lifetimes to create an outsized rate of return* How cryptocurrencies are changing finance, currencies, and banking, and it is only the beginning* How to participate in investments that are normally reserved for people who are already multi-millionaires* Which digital assets to invest in, how, and why* How to keep and protect the wealth you createLinda is the host of the Be Wealthy & Smart podcast.The Light Between is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Get full access to The Light Between at thelightbetween.substack.com/subscribe

In this episode, Kevin and Dr. Wolf dive deep into the complex world of behavioral health in the emergency department. Too often, psychiatric patients are treated as though their visit is a carceral event—stripped of autonomy, dignity, and decision-making capacity. We explore the ethical dilemmas, systemic barriers, and practical challenges that emergency nurses face when caring for patients with behavioral health needs. Some links to the documents referenced during the episode: Ethnoracial disparities in care on a consultation-liaison service at an academic hospital Racial and ethnic disparities in emergency department restraint use: A multi center retrospective analysis Refining the model for an emergency department-based mental health nurse practitioner outpatient service Psychiatric Emergencies and the Potential Role of Psychiatric–Mental Health Nurse Practitioners Follow us on: Facebook: https://www.facebook.com/Art-of-Emergency-Nursing-276898616569046/ YouTube: https://www.youtube.com/channel/UCJTnz4phtCTjojTIDJo2afA?view_as=subscriber Twitter: @AoenPodcast Instagram: https://www.instagram.com/artofemergencynursing/ To support the show: Leave an honest review on iTunes. Your ratings and reviews greatly contribute to the success of the podcast, and I appreciate each and every one of them. Subscribe on Apple Podcasts, Google Podcasts, or your preferred podcast platform to never miss an episode. Thank you for being a part of our AOEN community!

In this episode of Good Morning Liberty, Nate discusses the recent escalation in the Russia-Ukraine war following President Biden's approval for Ukraine to use long-range American-made missiles against Russia. Charles 'Chuck' Thompson is absent, and Nate covers significant events like the use of ATACMS missiles by Ukraine and President Putin's reaction to lower Russia's nuclear weapon threshold. The episode delves into the implications of these actions, possible reasons behind them, and the broader impact on global politics, including Trump's potential influence as the newly elected president. Nate also touches on the bankruptcy filing of Spirit Airlines, analyzing the potential repercussions on the airline industry due to the blocked merger with JetBlue. Tune in for an in-depth analysis of these current events and their potential consequences. (01:20) Ukraine Conflict Update (04:23) Escalation and Nuclear Threats (07:32) Possible Motivations Behind the Escalation (09:42) Trump's Potential Role and Negotiations (13:29) Military Industrial Complex and War Profiteering (29:14) Spirit Airlines Bankruptcy and Government Intervention (37:51) Conclusion and Upcoming Episodes  

PREVIEW: ARGENTINA/U.S. RELATIONS: Secure Free Society's Joseph Humire reports from Florida on emerging Milei-Trump dialogues - exploring U.S. investment potential in Argentina and Buenos Aires' potential role as showcase for U.S. Latin America policy. More later. 1900 Buenos Aires

Welcome back to UNBIASED. In today's episode: Trump Nominates RFK Jr. for HHS Secretary Position (0:39) Family of Malcom X Files $100M Lawsuit Against NYPD and US Government (7:38) Answering Your Most Frequently Asked Questions About Potential Dismantling of Education Dept. (11:08) Quick Hitters: Biden Gives Ukraine 'OK' to Use Long-Range Missiles in Russia, Jack Smith Pauses Appeal of Trump's Classified Documents Case, Spirit Airlines Files for Bankruptcy, AAA Releases Thanksgiving Holiday Travel Predictions (21:11) Listen/Watch this episode AD-FREE on Patreon. Watch this episode on YouTube. Follow Jordan on Instagram and TikTok. All sources for this episode can be found here.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Good Morning Liberty, hosts Nathaniel Paul Thurston and Charles Lawrence Thompson discuss Trump's intriguing new appointments, including Elon Musk and Vivek Ramaswamy heading the non-existent Department of Government Efficiency (DOGE). Despite some skepticism from libertarians about the practicality and implications of such a move, there is cautious optimism about the exposure and potential reduction of government waste. They also delve into Pete Hegseth's appointment as Secretary of Defense, John Ratcliffe for CIA Director, and the promising pick of Lee Zeldin for EPA head with plans to dismantle burdensome climate regulations. The hosts offer a nuanced take, blending hope for net positives with a realistic acknowledgment of the challenges ahead. Tune in for an in-depth analysis of these significant political moves and their possible impacts on the future of U.S. governance. (01:55) Trump's Cabinet Appointments (03:16) Department of Government Efficiency Announcement (06:20) Reactions and Critiques (16:28) Libertarian Perspectives (23:11) Debunking Misconceptions About Government Agencies (24:32) Dogecoin's Surprising Performance (25:39) The Debate on Government Spending (26:58) Trump's Controversial Cabinet Picks (28:01) Pete Hegseth: The New Secretary of Defense (30:53) Women in Combat Roles: A Heated Discussion (32:12) John Ratcliffe and the CIA (33:24) Lee Zeldin for the EPA (35:57) RFK's Potential Role in the Government (40:18) Closing Thoughts and Reflections

During this episode I learn more about Relative energy deficiency in sport and take you along for the ride.   REDs is a condition relating to energy in vs energy out. It's often talked about in the context of elite level sport, training and its potential negative health and performance effects on athletes and individuals.  During this episode I talk about common topics being discussed surrounding REDs, clinical guidelines that are available to help practitioners better understand REDs, as well the topic of sport culture's influence on athletes perception of body weight, body fat, body composition and weight management.  *Episode Resources* Mountjoy M et al. International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57(17):1073-1097. doi: 10.1136/bjsports-2023-106994 la Torre ME et al. The Potential Role of Nutrition in Overtraining Syndrome: A Narrative Review. Nutrients. 2023;15(23):4916. doi: 10.3390/nu15234916.

In the latest episode of Capitalist Investor, our hosts Diamond Hands D and Luke delve into some riveting topics that are heavily influencing the current economic and political landscapes. From election outcomes to Elon Musk's potential government role, and even the state of cryptocurrency, there's a lot to unpack. Here are the five hot topics discussed in the episode.1. Election Outcomes and Betting OddsThe imminent election was top of mind for both hosts, as they speculated on the potential outcomes and the implications for the market. Betting odds favor Trump, with odds sitting at an all-time high of 65 to 67%. However, they also acknowledged that the actual state polls may tell a different story, especially in key swing states like Pennsylvania, Michigan, and Arizona. Diamond Hands D noted, "The odds are favoring Trump... but the polls, however, tell a different story."2. Election Night UncertaintyOne of the pressing questions was whether or not we will have a decisive winner immediately after the election. The hosts discussed the possibility of delays, considering that multiple states have said they might not have results for two or three days post-election. Luke expressed his frustration, saying, “We should know. We should be able to count the votes up on that night and let the American people know who won.”3. Potential Role of Elon Musk in GovernmentThe conversation veered into speculative territory concerning Elon Musk's possible role in Trump's administration, should he win. Musk has been a frequent name on the campaign trail, and the idea of him leading a Department of Efficiency was floated. Luke joked about Musk's energy, “I just don't know how the guy can sleep... he's bringing something else to the campaign trail.”4. Government Spending and the EconomyGovernment spending remains a significant focus for the hosts, especially regarding its role in driving inflation. Diamond Hands D asserted, "If you had a pinpoint one problem that you can fix... Government spending is definitely number one on the list." They both agreed that reducing government spending is crucial for long-term economic sustainability and controlling inflation.5. Cryptocurrency: A Safe Haven?Finally, the episode covered the current boom in cryptocurrency, particularly Bitcoin, claiming its role as a hedge against traditional market volatility. The hosts debated whether Bitcoin is diversifying away from the U.S. Dollar and other currencies or if it serves more as a digital gold for inflation hedging. The episode was a deep dive into the interplay between these topics and how they might shape not just the coming weeks but also the broader future of the U.S. economy. With a mix of informed speculation and analysis, Capitalist Investor continues to offer listeners a valuable look into the economic and political trends that matter most. Don't miss out on next week's episode! 

Featuring an interview with Dr Erika Hamilton, including the following topics: Pathophysiology and pharmacology of ER-positive breast cancer treatment (0:00) Clinical evidence available with oral selective estrogen receptor degraders (3:46) Mechanism of action of proteolysis-targeting chimeras (PROTACs) (13:22) PROTACs currently in clinical development (16:39) Case: A woman in her late 30s with HR-positive, HER2-negative metastatic breast cancer (mBC) experiencing progression on a CDK4/6 inhibitor (CDK4/6i) and an aromatase inhibitor (AI) (35:09) Case: A woman in her early 70s with HR-positive, HER2-negative mBC that progresses on a CDK4/6i and an AI (41:16) CME information and select publications

Featuring a slide presentation and related discussion from Dr Erika Hamilton, including the following topics: Targeted therapies for ER-positive breast cancer (0:00) Clinical data with oral selective estrogen receptor degraders (2:13) Biological rationale for and mechanism of action of proteolysis-targeting chimeras (PROTACs) (7:07) Emerging data with PROTACs for ER-positive advanced breast cancer (9:17) Future directions with PROTACs for breast cancer (19:21) CME information and select publications

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPROTACmBC24).

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer.

CancerNetwork® spoke with James R. Berenson, MD, about the potential role that JAK inhibitors may play in the treatment of patients with multiple myeloma. The conversation focused on the rationale for researching this drug class as well as ongoing initiatives to assess the utility of agents like ruxolitinib (Jakafi) for this patient population. Berenson, founder, medical and scientific director, and president and chief executive officer of the Institute for Myeloma and Bone Cancer Research and private practitioner in West Hollywood, California, described the factors associated with the overexpression of JAK in the bone marrow, which may constitute a prime survival factor for multiple myeloma. This overexpression may affect the checkpoint inhibitor proteins in the body, resulting in resistance to standard anti-myeloma therapies such as immunomodulatory drugs.  Additionally, he mentioned a patient case that had involved a scenario in which JAK-mutated multiple myeloma progressed following prior treatment with lenalidomide (Revlimid). According to Berenson, the disease's resistance to lenalidomide was primarily associated with proteins driven by JAK; subsequent treatment involving JAK inhibition proved successful in restoring the efficacy of lenalidomide.  Based on a rationale to target JAK overactivity in the bone marrow and results from this patient case, Berenson and colleagues have focused on researching ruxolitinib as a therapeutic candidate for potentially improving outcomes in multiple myeloma via JAK inhibition. Findings from a phase 1 trial (NCT03110822), for example, have demonstrated that the efficacy and tolerability of ruxolitinib plus methylprednisolone can be extended with lenalidomide in those with multiple myeloma. Additionally, other ongoing trials aim to combine ruxolitinib with agents such as selinexor (Xpovio). “The question is, where will ruxolitinib sit in the sequencing of treatment of [patients with] multiple myeloma? Where will selinexor be?” Berenson stated. “At this point, there's certainly been low use of these drugs, especially ruxolitinib in multiple myeloma. We hope, with a more positive signal, these drugs will move further up in the algorithm of how you treat multiple myeloma.” Reference Berenson JR, Limon A, Rice S, et al. A phase I trial evaluating the addition of lenalidomide to patients with relapsed/refractory multiple myeloma progressing on ruxolitinib and methylprednisolone. Target Oncol. 2024;19(3):343-357. doi:10.1007/s11523-024-01049-w

I get a little giddy when I come across a novel mitochondrial-boosting strategy; particularly, when its mechanisms of how it impacts the mitochondria aren't redundant with other powerful modalities, such as red light therapy, methylene blue and C60. Of course, it must also be safe, efficacious and backed by research for it to even be a consideration. Well, ladies and gentleman, the amino acid taurine fits that bill to a tee!If you're like me, taurine may have a knee-jerk negative connotation due to its association with energy drinks. But if that's the case, I politely ask you to table that association as we head into this episode. The more I have learned about this mysteriously overlooked amino acid, and its science-backed efficacy for improving mitochondrial function in a myriad of way, the more I have gotten excited to report this information to you. Taurine is the real deal!In this episode, I will be providing "knowledge snacks" from a textbook I recently read, "Taurine and the Mitochondrion: Applications in the Pharmacotherapy of Human Diseases." The chapters and information covered in part one include the synthesis, dietary sources, and mechanisms of action of taurine; taurine and the mitochondrion; and applications of taurine in the central nervous system disorders linked with mitochondrial impairment. Subsequent parts of this series will cover other diseases and body systems impacted by mitochondrial dysfunction and how taurine may play a pivotal role in mitigating, preventing and/or reversing aforementioned conditions. If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :)As always, light up your health! - Book referenced in episode: Taurine and the Mitochondrion: Applications in the Pharmacotherapy of Human Diseases - Key Points: [00:00] - Introduction: Welcome to the Red Light Report. [00:13] - Mitochondrial Triad and Happy Autumn Equinox. [00:50] - Announcements: Recap of oral health benefits of red and blue light, introduction of Illume toothbrush. [01:22] - Illume Toothbrush: Pre-orders fulfilled, benefits of red and blue frequencies for oral health. [02:12] - Upcoming: Biological dentists' feedback on Illume toothbrush. [02:33] - Today's Topic: Taurine and its role in health. [03:05] - Misconceptions about Taurine: Association with energy drinks. [04:09] - Taurine's Impact on Mitochondria: Bioenergetic benefits and physiological function. [05:11] - Mitochondrial Function: Root cause of chronic diseases and health optimization. [06:15] - Taurine and Mitochondria: Chapter overview of taurine's impact on various systems. [08:21] - Taurine's Mechanisms: Redundancy across different organ systems. [09:45] - Taurine Book Introduction: Overview and authors. [11:07] - Taurine Benefits: Impact on various organs and its role in pharmacological processes. [12:30] - Taurine Synthesis and Dietary Sources: Differences between species and taurine-rich foods. [13:51] - CSD Activity and Taurine Deficiency: Synthesis in humans and food sources like oysters. [15:04] - Taurine in Energy-Intensive Organs: Concentrations in the brain, heart, and muscles. [16:43] - Mitochondrial Dysfunction: How taurine impacts high-energy organs. [18:27] - Taurine's Role in Calcium Homeostasis: Buffering overload and stabilizing mitochondrial function. [19:59] - Chapter 2: Taurine's cytoprotective properties in mitochondria. [21:18] - Taurine & Mitochondrial Function [22:10] - Clarifying Cytochrome C vs Cytochrome C Oxidase [23:39] - Taurine & Mitochondrial ATP Production [25:53] - Taurine's Role in Cellular Calcium Regulation [27:33] - Applications of Taurine in the Central Nervous System [28:42] - Excitotoxicity & Neurodegenerative Diseases [29:57] - Questioning Nitric Oxide Benefits [32:24] - Taurine & Stroke Protection [35:11] - Taurine & Traumatic Brain Injury (TBI) [39:23] - Taurine & Seizures/Epilepsy [41:15] - Taurine & Neurodegenerative Disorders [42:02] - Introduction to Taurine and Alzheimer's Disease [42:16] - Taurine's Role in Preventing Amyloid Beta Aggregation [43:04] - Mitochondrial Impairment in Parkinson's Disease [44:07] - Taurine's Impact on Dopaminergic Neurons [45:32] - Taurine's Potential Role in Huntington's Disease [46:16] - Taurine's Mitochondrial Benefits in Huntington's Disease Models [47:18] - Excitotoxicity and NMDA Receptor Hyperactivation in Huntington's Disease [48:30] - Taurine's Effect on GABA Levels in Huntington's Disease [50:14] - BioLite Product Announcement: BioBlue Capsules [51:12] - Advantages of BioBlue Capsule Version [52:05] - Capsule Ingredients: Methylene Blue and Taurine [53:18] - Dosage Details for BioBlue Capsules [57:03] - Benefits of Methylene Blue and Taurine for Mitochondria [58:34 - Coupon Code and Pre-Order Information [59:46] - Conclusion and Teaser for Part Two on Taurine -   Announcing BioLight's most innovative product: BioLight Illume! BioLight's patent-pending technology brings the power of red and blue LEDs into a sonic toothbrush. Now your mouth can receive the many benefits of red and blue light!   For the rest of September, order your Illume toothbrush and get a 15% discount! Simply use discount code "illume15"   To light up your smile, click here - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Cyber Security Expert Theresa Payton joins Bo and Beth to give some insight on Mark Robinson's claim that his recent scandal is a result of an A.I. smear campaign by Democrats.See omnystudio.com/listener for privacy information.

In this episode, I analyze the surprising decision of Robert F. Kennedy Jr. to suspend his presidential campaign and endorse Donald Trump, examining the potential ripple effects on the upcoming election. I address several key questions, such as how this decision could influence voter behavior, affect fundraising dynamics, and reshape election strategies for both Trump and Kamala Harris. I delved into my personal experience with RFK Jr., including his appearance on my podcast where he discussed his contentious views on vaccines, which I initially chose not to release due to their controversial nature and my inability to fact-check them at the time.Additionally, I provide a historical perspective by examining past elections where third-party candidates acted as spoilers, such as Ralph Nader in the 2000 election and Theodore Roosevelt in the 1912 election. These examples highlight the significant impact a third-party candidate can have on election outcomes. The script further explores RFK Jr.'s speech and newly expressed concerns about chronic diseases, obesity, and ultra-processed foods in the U.S., comparing his claims with available data and trends.I also address the concept of corporate capture of federal agencies like the FDA, providing examples of former FDA officials who moved to high-level positions in pharmaceutical companies. This discussion includes RFK Jr.'s claim that 50 percent of the FDA's funding comes from pharmaceutical companies through user fees, raising concerns about potential conflicts of interest.Moreover, I discuss RFK Jr.'s potential future role in a Trump administration, focusing on health policy issues, and his influence on current polling dynamics. I fact-check several of his statements and analyze their implications for American health and longevity, contrasting U.S. life expectancy with that of other countries. Finally, I explore economic policies proposed by Kamala Harris and their potential impact on the U.S. economy, emphasizing RFK Jr.'s emphasis on children's health and the possible consequences of his alignment with Trump for the upcoming election. This detailed analysis aims to provide viewers with a nuanced understanding of RFK Jr.'s endorsement and its broader political and social implications.00:00 Introduction and Setting the Scene00:14 Robert F. Kennedy Jr.'s Campaign Suspension00:47 Personal Reflections on Vaccines04:03 Impact of Third-Party Candidates in Elections06:38 Historical Spoiler Elections13:23 RFK Jr.'s Concerns and Endorsement of Trump22:49 Polling Dynamics and Election Predictions27:52 RFK Jr.'s Potential Role in a Trump Administration30:04 Fact-Checking RFK Jr.'s Claims on Health Issues34:14 Big Pharma: Friend or Foe?34:34 The Decline of Smoking and Its Impact on Life Expectancy35:34 Comparing Life Expectancy Across Countries37:01 The Role of Ultra-Processed Foods in American Health39:37 RFK Jr.'s Controversial Views on Vaccines41:43 The Impact of RFK Jr.'s Political Moves46:39 Corporate Capture and Its Consequences51:59 Economic Policies and Their Implications54:46 RFK Jr.'s Focus on Children's Health58:30 Final Thoughts and Listener Questions ------------What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!------------Visit Notepd.com to read our idea lists & sign up to create your own!My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.I write about all my podcasts! Check out the full post and learn what I learned at jamesaltuchershow.com------------Thank you so much for listening! If you like this episode, please rate, review, and subscribe to “The James Altucher Show” wherever you get your podcasts: Apple PodcastsiHeart RadioSpotifyFollow me on social media:YouTubeTwitterFacebookLinkedIn

In this episode, I analyze the surprising decision of Robert F. Kennedy Jr. to suspend his presidential campaign and endorse Donald Trump, examining the potential ripple effects on the upcoming election. I address several key questions, such as how this decision could influence voter behavior, affect fundraising dynamics, and reshape election strategies for both Trump and Kamala Harris. I delved into my personal experience with RFK Jr., including his appearance on my podcast where he discussed his contentious views on vaccines, which I initially chose not to release due to their controversial nature and my inability to fact-check them at the time.Additionally, I provide a historical perspective by examining past elections where third-party candidates acted as spoilers, such as Ralph Nader in the 2000 election and Theodore Roosevelt in the 1912 election. These examples highlight the significant impact a third-party candidate can have on election outcomes. The script further explores RFK Jr.'s speech and newly expressed concerns about chronic diseases, obesity, and ultra-processed foods in the U.S., comparing his claims with available data and trends.I also address the concept of corporate capture of federal agencies like the FDA, providing examples of former FDA officials who moved to high-level positions in pharmaceutical companies. This discussion includes RFK Jr.'s claim that 50 percent of the FDA's funding comes from pharmaceutical companies through user fees, raising concerns about potential conflicts of interest.Moreover, I discuss RFK Jr.'s potential future role in a Trump administration, focusing on health policy issues, and his influence on current polling dynamics. I fact-check several of his statements and analyze their implications for American health and longevity, contrasting U.S. life expectancy with that of other countries. Finally, I explore economic policies proposed by Kamala Harris and their potential impact on the U.S. economy, emphasizing RFK Jr.'s emphasis on children's health and the possible consequences of his alignment with Trump for the upcoming election. This detailed analysis aims to provide viewers with a nuanced understanding of RFK Jr.'s endorsement and its broader political and social implications.00:00 Introduction and Setting the Scene00:14 Robert F. Kennedy Jr.'s Campaign Suspension00:47 Personal Reflections on Vaccines04:03 Impact of Third-Party Candidates in Elections06:38 Historical Spoiler Elections13:23 RFK Jr.'s Concerns and Endorsement of Trump22:49 Polling Dynamics and Election Predictions27:52 RFK Jr.'s Potential Role in a Trump Administration30:04 Fact-Checking RFK Jr.'s Claims on Health Issues34:14 Big Pharma: Friend or Foe?34:34 The Decline of Smoking and Its Impact on Life Expectancy35:34 Comparing Life Expectancy Across Countries37:01 The Role of Ultra-Processed Foods in American Health39:37 RFK Jr.'s Controversial Views on Vaccines41:43 The Impact of RFK Jr.'s Political Moves46:39 Corporate Capture and Its Consequences51:59 Economic Policies and Their Implications54:46 RFK Jr.'s Focus on Children's Health58:30 Final Thoughts and Listener Questions ------------What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!------------Visit Notepd.com to read our idea lists & sign up to create your own!My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.I write about all my podcasts! Check out the full post and learn...

- HISTORIC Announcement: RFK Jr's Potential Role in Trump's Administration - Critique of Kamala Harris's disastrous economic policies - RFK Jr's Endorsement and Its Impact on the Election - Historical Comparisons and the Importance of RFK Jr's Endorsement - The Role of Wealthy Jewish Donors in a Trump Victory - The Importance of Saving America First - Support for Trump and RFK Jr's Endorsement - Interview with Scott Wiper and the "Flynn" Movie - Mike Adams Sermon #025 - Isaiah 28 - Black CUMIN SEED is God's natural medicine found in ancient food For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

While GLP-1 agonists continue to gain popularity in the medical management of diabetes and obesity, Dr. Cliff Weiss is exploring bariatric arterial embolization (BAE) as an adjunctive therapy to help patients sustain weight loss. Dr. Weiss, the Director of IR Research at Johns Hopkins, joins the show to discuss the techniques and impacts of BAE for obesity treatment. --- CHECK OUT OUR SPONSOR Reflow Medical https://www.reflowmedical.com/ --- SYNPOSIS Dr. Weiss outlines his initial research interest in gastric embolization of the fundus to reduce ghrelin production. He began by studying the use of sclerosants for embolization but later shifted to using embolic spheres. BAE involves the targeted embolization of the left gastric artery, with or without the left gastroepiploic artery, using 300-500 micron embolic spheres. Dr. Weiss also employs a dilute mixture of spheres and a vasodilator to achieve distal arterial penetration. He describes the role of BAE in conjunction with existing surgical and pharmaceutical treatments. According to his experience, patients undergoing BAE achieve maximum weight loss 6-9 months after the procedure and can maintain this weight when they follow up in a weight management clinic. Additionally, Dr. Weiss reviews data from BAE studies, including the BEAT Obesity Trial and the recent BEATLES Trial. --- TIMESTAMPS 00:00 - Introduction 03:21 - Early Research and Development of BAE 07:39 - Potential Role of BAE in Obesity Treatment 16:03 - Procedure Details 25:28 - Post-Procedure Care and Patient Management 28:06 - Insights from the BEAT Obesity Trial 33:38 - BEATLES Trial 37:38 - Combination Therapy for Obesity --- RESOURCES BEAT Obesity Trial: https://pubs.rsna.org/doi/full/10.1148/radiol.2019182354 LC Bead/Bead Block: https://www.bostonscientific.com/en-US/products/embolization/lc-bead.html EmboSpheres: https://www.merit.com/product/embosphere-microspheres/ EMBIO Trial: https://bmjopen.bmj.com/content/13/9/e072327 BEATLES Trial: https://www.jvir.org/article/S1051-0443(23)01155-7/fulltext

Featuring perspectives from Dr Melissa Johnson, Dr Ticiana Leal and Dr Manish Patel, including the following topics: Introduction: Two Faces of Lung Cancer Research (0:00) B7-H3-Targeted Antibody-Drug Conjugates for Lung Cancer — Dr Patel (16:14) Potential Role of Tumor Treating Fields in the Management of Metastatic Non-Small Cell Lung Cancer — Dr Leal (32:36) Emerging Role of Bispecific T-Cell Engaging Immunotherapy in Small Cell Lung Cancer — Dr Johnson (46:14) CME information and select publications

05:40 Cult-Like Behavior Among AEW Fans10:20 Vince McMahon's Rumored Return and AEW Takeover Speculations15:45 Shane McMahon's Potential Role in AEW20:30 WWE's Streaming Issues and Netflix Deal Expectations35:30 Classic Wrestling Moves and Their Disappearance40:10 Local Promotions and the Evolution of Wrestling in Ireland45:00 Conspiracy Theory Album by Finn the Dog50:20 Tony Khan's Blame Game and AEW's Booking Issues01:00:00 Classic Wrestling Segments and Finishing Moves01:05:20 AEW's Missteps and WCW Comparisons01:10:00 The Impact of Social Media on Wrestling Promotionshttps://gofund.me/50fae5bcDonate to help LuFisto- Support Wrestling Soup on Patreon:https://www.patreon.com/wrestlingsoupSOCIAL CHANNELS ʕ̡̢̡ʘ̅͟͜͡ʘ̲̅ʔ̢̡ʢTwitter: https://twitter.com/WrestlingSoupInstagram: https://www.instagram.com/wrestlingsoup/Facebook: https://www.facebook.com/WrestlingSoup/Discord Channel: https://discord.gg/wrestlingsoup:shirt: PRO WRESTLING TEES STORE :shirt: ／(=✪ x ✪=)＼Become a supporter of this podcast: https://www.spreaker.com/podcast/wrestling-soup--1425249/support

Psilocybin has had a place in healing for millennia, particularly among ancient civilizations and cultures. While it's had a negative view in some corners of contemporary American society, research into its potential has gained traction and it is slowly finding a place in the mainstream. In this episode, Dr. Mulder and Dr. Beckrow are joined by Prof. Michael DeWilde, who shares his knowledge of the history, uses, and benefits of psilocybin. This has prompted Dr. Mulder and Dr. Beckrow to ask, "Is there a place for psilocybin in palliative medicine and end-of-life care?"

On this edition of the ArsenalVision Podcast, Elliot is joined by Clive to discuss Arsenal's game against Liverpool in Philadelphia and Mikel Merino's possible arrival. The pod starts with questions about specific performances against Liverpool, most notably Thomas Partey, Zinchenko, Jesus and Martinelli. That discussion leads into questions about midfield configurations which leads to the conversation about Merino's imminent arrival at Arsenal and what role he could play. Other performances against LFC are analyzed, including Skelly, Vieira, Eddie and others, before attention turns to transfers again. The pod discusses what additional business might get done this window then finishes on thoughts about final preparations for the season. All that and more on this edition of the ArsenalVision Podcast. Signup for our Patreon at patreon.com/arsenalvisionpodcast Interested in advertising on this podcast? Email sales@bluewirepods.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Featuring perspectives from Dr John N Allan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, including the following topics: Introduction (0:00) First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) (11:44) The Impact of Comorbid Conditions on the Choice of First-Line Therapy for Newly Diagnosed CLL (18:08) Toxicities and Other Practical Considerations with Venetoclax-Based Treatment (25:17) The Selection and Sequencing of Therapies for Relapsed/Refractory CLL (35:45) The Tolerability of Available Bruton Tyrosine Kinase (BTK) Inhibitors (40:43) The Potential Role of Therapy Combining BTK Inhibitors and Venetoclax (48:48) Bispecific Antibodies as a Treatment Option for Non-Hodgkin Lymphoma (1:04:19) Cytokine Release Syndrome and Neurotoxicity with Bispecific Antibodies (1:06:25) Other Tolerability and Toxicity Issues with Bispecific Antibody Therapy (1:10:44) Bispecific Antibodies for the Management of Follicular Lymphoma (1:18:19) The Role of Bispecific Antibody Therapy in the Treatment of Diffuse Large B-Cell Lymphoma (1:24:17) Other Practical Considerations with the Use of Bispecific Antibodies (1:40:59) NCPD information and select publications

Featuring perspectives from Ms Deanna A Griffie, Ms Caroline Kuhlman, Dr Manish A Shah and Dr John Strickler, including the following topics: Introduction (0:00) The Current Role of Anti-PD-1/PD-L1 Antibodies in the Management of Nonmetastatic Gastroesophageal Cancers (11:30) The Potential Role of Immune Checkpoint Inhibitors (ICIs) as Neoadjuvant Therapy for Patients with Gastric/Gastroesophageal Junction Cancer (20:53) First-Line Therapy for Metastatic Gastroesophageal Cancers (36:16) The Potential Role of Therapy Targeting Claudin 18.2 for Gastroesophageal Cancers (42:16) Targeted Therapies for HER2-Positive Gastroesophageal Cancers (51:42) Selection of Appropriate Candidates with Localized Colorectal Cancer (CRC) for Adjuvant Therapy (1:14:24) The Current Role of ICIs in the Treatment of Metastatic CRC (mCRC) (1:23:32) Tolerability and Other Practical Considerations with ICIs (1:25:57) The Role of TAS-102/Bevacizumab in the Management of Relapsed/Refractory (R/R) mCRC (1:36:14) The Potential Role of KRAS-Targeted Therapy in the Management of mCRC (1:44:36) NCPD information and select publications

Former Macalester star and 2023-24 1st Team MIAC player, Caleb Williams joins "Not Even D2" on this week's episode. After a senior season averaging 20.0 points per game, Caleb is taking his talents to the Division 1 level. Williams had a historic performance in an exhibition game against Minnesota (D1) scoring 41 points. Shortly after his season ended, Caleb heard from plenty of high major Division 1 schools, and ultimately decided to commit to Minnesota. Hear more about Caleb's career at Macalester, the popularity after his 41 point performance, and what Caleb's goals are heading into his final season of college basketball playing in a Power 5 conference. This episode is available wherever you get your podcasts. Subscribe to the podcasts YouTube channel for more Division 3 content. Enjoy the episode! Intro- 00:00-04:20 Off-season Focus: 04:20-05:02 NBA Finals Predictions: 05:02-06:13 Recruitment Process/Choosing Macalester- 06:13-08:25 Basketball in Wisconsin- 08:25-09:40 Expectations for Senior Season- 09:40-10:47 Developing a Scoring Bag- 10:47-12:17 Dealing with Challenges at Macalester- 12:17-13:29 41p Performance @ Minnesota- 13:29-16:29 Going Viral after Minnesota Game- 16:30-18:05 Impact Minnesota Game had on Macalester- 18:05-19:32 51p Performance Against Concordia- 19:32-21:00 Break- 21:00-21:07 Committing to Minnesota- 21:07-23:33 Potential Role at Minnesota- 23:33-24:32 Mindset Ahead of Playing in the Big 10- 24:32-25:56 Advice from Former MIAC Players- 25:56-26:49 Perspective on Division 3 Basketball- 26:49-28:32 Opinion on the MIAC: 28:32-30:03 Excelling as a Student: 30:03-31:49 Changing from the D3 to D1 Lifestyle: 31:49-33:32 Rapid Fire: 33:32-35:35 Starting 5: Players Played With or Against- 35:35-37:31 Outro- 37:31-38:14

Featuring perspectives from Ms Courtney Arn, Dr Floor J Backes, Dr Kathleen N Moore and Ms Jaclyn Shaver, including the following topics: Introduction: The Incidence, Pathogenesis and Prognosis of Ovarian Cancer (0:00) Genetic Testing for Newly Diagnosed Advanced Ovarian Cancer (11:01) The Role of PARP Inhibitor Maintenance for Newly Diagnosed Advanced Ovarian Cancer (19:02) Side Effects Associated with PARP Inhibitors (29:58) Dosing, Adherence and Other Issues with PARP Inhibitors for Ovarian Cancer (48:29) The Potential Role of PARP Inhibitors in Combination with Anti-PD-1/PD-L1 Antibodies for Advanced Ovarian Cancer Management (54:11) PARP Inhibitors for Relapsed/Refractory Ovarian Cancer (1:00:36) The Current Role of Mirvetuximab Soravtansine for Ovarian Cancer Treatment (1:07:14) Toxicities with Mirvetuximab Soravtansine (1:11:53) The Incidence and Management of HER2-Positive Ovarian Cancer (1:18:18) NCPD information and select publications

Joe Pags Exclusive: Texas AG Ken Paxton Discusses Potential Role as Trump's Attorney General and Shares Insights on NYC Trial. Learn more about your ad choices. Visit megaphone.fm/adchoices

Zach and Josh give their thoughts on Keon Coleman and what he can do for the Bills. 

Featuring perspectives from Ms Blanca Ledezma, Dr Stacey Stein, Ms Amanda K Wagner and Dr Mark Yarchoan, including the following topics: Introduction (0:00) Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma (HCC) (9:40) Role of Immunotherapy in Intermediate-Stage HCC (17:02) First-Line Therapy for Advanced HCC (19:56) Immunotherapy in the Management of Advanced Biliary Tract Cancers (BTCs) (44:29) Biomarker Testing Recommendations and the Use of FGFR Inhibitors for Advanced Cholangiocarcinoma (58:02) Potential Role of HER2-Targeted Therapy for BTCs (1:17:16) CME information and select publications  

Featuring perspectives from Ms Jennifer Filipi, Ms Kathryn Lyle, Dr David O'Malley and Dr Shannon N Westin, including the following topics: Introduction (0:00) Incidence and Biology of Endometrial Cancer (EC) (9:30) Use of Immune Checkpoint Inhibitors as Monotherapy for EC (23:24) First-Line Therapy for Primary Advanced or Recurrent EC (28:28) Lenvatinib/Pembrolizumab in the Management of Metastatic EC (1:05:08) Potential Role of Selinexor in the Management of EC (1:13:20) Incidence and Management of HER2-Positive EC (1:22:51) NCPD information and select publications

0:00 - Introduction and Astros Sweep 0:36 - Rated R Warning and Podcast Content Notice 1:01 - Bourbon&Baseball Intro and Mistaken Directions 1:23 - Catching up with Tom about the #Astros 1:50 - Upcoming Homestand Against #ClevelandGuardians and #SeattleMariners 2:41 - Pitching Challenges and Comparisons 3:27 - #JoeyLoperfido 's Call-Up and Roster Moves 4:06 - Discussion on Joey Loperfido's Potential Play Time and Position 5:08 - Speculations on Astros' First Base Strategies 6:00 - Joey Loperfido's Impact and Performance in Triple-A 7:00 - Joey Loperfido's Defense and Potential in MLB 8:06 - Comparisons to Other Players and Joey Loperfido's Stats 11:01 - Further Discussion on Astros' Current and Upcoming Matches 12:59 - Debate on Astros' Rotation and Player Performances 15:00 - Detailed Discussion on Individual Player Performances and Team Strategy 20:29 - Hunter Brown's Potential Role and Future in Pitching 23:00 - Astros' Game Strategies and Fan Expectations 25:15 - Analyzing Astros' Performance and Future Games 30:07 - Joey Loperfido's Performance Against Right-Handed Pitching 32:16 - Expectations from Upcoming Mariners Series 35:02 - Podcast Wrap-Up and Plans for Next Episodes 37:09 - Additional Discussion on Player Deployment and Team Dynamics 39:22 - Tom's Social Media and Interaction Suggestions 42:36 - Closing Remarks and Future Podcast Plans

Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, including the following topics. Current and Potential Role of Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancers — Dr Klempner (0:00) Other Available and Emerging Therapeutic Approaches — Dr Janjigian (31:42) CME information and select publications

What if AI could understand what we, humans, are feeling? This week on Generative Now, Lightspeed Partner and host Michael Mignano talks to Alan Cowen, a researcher, founder and CEO of Hume AI. Hume creates empathic AI that learns our preferences from our vocal and facial expressions. Their goal is to maximize our happiness and quality of life. Hume is now announcing their API for EVI, Hume's Empathic Voice Interface.  The conversation covers Cowen's journey from being a researcher to founding Hume AI, the importance of emotional intelligence in AI for quality human interaction, and the potential to transform user experiences across various apps and devices. Plus, we ask how emphatic AI could impact the road to AGI. Episode Chapters(00:00) Introduction to Alan Cowen & Hume Demo  (01:38) The Genesis of Hume AI: From Research to Startup (04:01) Affective Computing and Its Impact (10:55) Hume AI: Bridging Human Emotions and Technology (15:37) The Future of AI: Beyond Text to Empathic Interactions (20:37) Introducing EVI: Empathic Voice Interface (21:46) Real-World Applications of Empathic AI  (31:19) The Potential Role of Empathic AI in Achieving AGI (36:53) Trust and Privacy (40:02) Opportunities with Hume AI (41:18) Closing Thoughts  Stay in touch: www.lsvp.com X: https://twitter.com/lightspeedvp LinkedIn: https://www.linkedin.com/company/lightspeed-venture-partners/ Instagram: https://www.instagram.com/lightspeedventurepartners/ Subscribe on your favorite podcast app: generativenow.co Email: generativenow@lsvp.com The content here does not constitute tax, legal, business or investment advice or an offer to provide such advice, should not be construed as advocating the purchase or sale of any security or investment or a recommendation of any company, and is not an offer, or solicitation of an offer, for the purchase or sale of any security or investment product. For more details please see lsvp.com/legal.

Featuring perspectives from Dr Joyce F Liu, Dr Mansoor Raza Mirza and Dr David M O'Malley, moderated by Dr Kathleen N Moore, including the following topics: Introduction (0:00) Current Up-Front Treatment for Advanced Ovarian Cancer (OC) — Dr Liu (2:06) Potential Role of Immunotherapeutic Strategies for Advanced OC — Dr O'Malley (25:12) Incorporation of Novel Therapies into the Management of Relapsed/Refractory OC — Dr Moore (48:23) Diagnosis and Management of Adverse Events Associated with Commonly Employed Therapies for Advanced OC — Dr Mirza (1:06:59) CME information and select publications

Featuring perspectives from Dr Robin (Katie) Kelley and Dr Mark Yarchoan, including the following topics:  Introduction: Interdisciplinary Management of Hepatocellular Carcinoma (HCC) in the Community (General Medical Oncology) Setting — Radiology, Hepatology, Pathology Support (0:00) Potential Role of Anti-PD-1/PD-L1 Antibodies in the Care of Patients with Early- and Intermediate-Stage HCC — Dr Yarchoan (8:09) HCC Rounds (22:07) Tolerability and Other Practical Considerations with the Use of Immune Checkpoint Inhibitors for Advanced HCC and Biliary Tract Cancers (BTCs) — Dr Kelley (39:25) Faculty Survey (49:19) BTC Rounds (52:19) CME information and select publications   

It's March Madness time! Welcome back to Sketching Up!  Join Chris and Matt in an exhilarating episode where they traverse various topics, from the excitement of March Madness and speculative fictional basketball drafts to the depths of comic lore with DC One Million and the anticipation surrounding the new X-Men release. They delve into the nuanced discussions on the potential success of mutants in the X-Men cartoon, the intricacies of continuing Tony Stark's legacy within the MCU, and offer their take on the latest from Invincible Season 2 on Amazon Prime. Key Discussions: March Madness & Fictional Basketball Draft: Delve into a fun-filled discussion where Chris and Matt select their dream teams of fictional basketball players from beloved movies and TV shows. The roster includes fan favorites like Chris Bosh from Parks and Rec, Uncle Drew, Charlie Day from It's Always Sunny in Philadelphia, and the iconic Will Smith from Fresh Prince. DC One Million & Collecting Encyclopedias: A thoughtful conversation on the DC One Million comic series and the hosts' personal anecdotes on collecting encyclopedias and books. X-Men Release & Animation Style: The hosts share their enthusiasm for the new X-Men series, discussing its animation style and how it might influence the portrayal of various mutants. Tony Stark's Legacy & MCU Challenges: Insight into the complexities of moving forward in the MCU without Tony Stark, including the significance of staying true to comic book source material. Invincible Season 2 Episode 5: An in-depth analysis of Invincible Season 2 Episode 5, focusing on the introduction of the Viltrumites, the challenges of juggling multiple storylines, and a critique of the Guardians of the Globe. Chapters: 00:00 - Introduction and Recap 01:31 - March Madness and Fictional Basketball Draft 02:55 - Discussion on DC One Million 04:26 - Potential TV Show Adaptation of DC One Million 05:31 - Failed Attempt to Get Grant Morrison on the Podcast 06:28 - Discussion on Collecting Encyclopedias and Books 07:26 - Challenges of Reading Comic Books While Traveling 08:26 - Reading Regular Books and Political Discussion 08:43 - Excitement for the Release of X-Men 09:12 - Discussion on the Animation Style of X-Men 09:39 - Plot and Characters of X-Men 11:05 - Exploring Xavier's Absence and Magneto's Role 12:03 - The Potential Role of Jubilee and Jean Grey's Pregnancy 13:28 - Speculation on the Success of Different Mutants 15:01 - The Significance of the X-Men Cartoon's Return 16:12 - Speculation on the Purpose of the X-Men Cartoon's Return 19:26 - The Importance of Staying True to the Source Material 21:20 - The Challenges of Continuing Tony Stark's Legacy 22:39 - The Impact of Tony Stark's Death in Endgame 23:50 - The Importance of Reading the Source Material 25:07 - The Need for Comic Book Knowledge in the MCU 26:05 - Discussion on Invincible Season 2 Episode 5 26:24 - Discussion about the release of Invincible on Amazon Prime 27:08 - The plot of Invincible and the introduction of the Viltrumites 28:22 - The challenge of fitting multiple storylines into the remaining episodes 30:06 - The return of Alan the Alien and the revelation of the Viltrumite 31:38 - The role of the Guardians of the Globe and their incompetence 33:21 - Speculation on the future of the show and the upcoming seasons 34:46 - Discussion about fictional basketball teams 45:29 - Drafting fictional basketball players 47:50 - Introduction and Draft Setup 48:19 - Chris Bosh from Parks and Rec 49:03 - Uncle Drew and Fictional Characters 49:54 - Charlie Day from It's Always Sunny in Philadelphia 50:36 - Will Smith from Fresh Prince 51:13 - Nathan Scott from One Tree Hill 51:50 - Bow Wow from Like Mike 52:32 - Andrew Garfield as Spider-Man 53:00 - Michael Scott as the Sixth Man 57:20 - Surprise Picks: Steve Urkel and Will Smith's High School Basketball Career

Seg 1- GG Jackson's potential role on a healthy Grizzlies team, Bane's play since return, JJJ's growth, and more Seg 2- Memphis spring practice and season expectations  

On this episode of the OnTrack Podcast, we welcome Phil Marcoux, Advisor to the Printed Circuit Engineering Association (PCEA). Phil is gearing up for a fascinating webinar on AI in the electronics industry, so we thought we'd chat with him about what sees as the most potentially transformative aspects of this revolution in the electronics space. Listen/watch to discover how Innovations in AI are transforming the electronics industry, reshaping everything from design to production. Phil and host, Tech Consultant Zach Peterson, explore real-world applications, the importance of data for AI's success, and how the industry is moving towards a more interconnected and intelligent (pun intended) future.   Key Highlights AI & Electronics Design: Explores the symbiotic relationship between artificial intelligence and electronics design, highlighting how AI is revolutionizing the field. Are We in an AI Bubble?: Raises critical inquiry into whether the current surge in AI development constitutes a bubble, prompting reflection on the sustainability and potential pitfalls of AI advancement. AI Can't Read Your Mind: Discusses the inherent limitations of AI in deciphering human thoughts and intentions, emphasizing the distinction between AI capabilities and human cognition. Trends from the Early Days of AI: Examines trends emerging from the early stages of AI development, providing valuable insights into its evolution and predicting potential future trajectories. A Potential Role for AI: Speculates on the future landscape of electronics design with AI integration, envisioning potential applications and transformative impacts on the industry. Further Resources Sign up for Phil's FREE Webinar Connect with Phil Marcoux Check out more episodes of the OnTrack Podcast Take advantage of exclusive 15 Days Free Altium Designer Access

The Cincinnati Bengals' coaching staff will look different in 2024. Will that lead to changes on offense for Zac Taylor, Joe Burrow and company? The guys answer that question, plus they talk about Tee Higgins' future, what the Bengals could do to address holes at running back, tight end and more! Join the Locked On Bengals Subtext Community! https://joinsubtext.com/lockedonbengals Find and follow Locked On Bengals on your favorite podcast platforms: Apple Podcasts: https://podcasts.apple.com/us/podcast/locked-on-bengals-daily-podcast-on-the-cincinnati-bengals/id1159723162 Spotify: https://open.spotify.com/show/7AObc0lh0WmQl5fJVgtajs Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vbG9ja2Vkb25iZW5nYWxz?sa=X&ved=0CAYQrrcFahcKEwio_sXtj8nuAhUAAAAAHQAAAAAQAg Stitcher: https://www.stitcher.com/show/locked-on-bengals Support Us By Supporting Our Sponsors! Jase Medical Empower yourself when you purchase a Jase Case, providing you with a personal supply of 5 antibiotics that treat 50+ infections. Get yours today at jasemedical.com and use code LOCKEDON to get $20 off your order. eBay Motors For parts that fit, head to eBay Motors and look for the green check. Stay in the game with eBay Guaranteed Fit at eBayMotos.com. Let's ride. eBay Guaranteed Fit only available to US customers. Eligible items only. Exclusions apply. BetterHelp This episode is sponsored by BetterHelp. Make your brain your friend, with BetterHelp. Visit BetterHelp.com/LOCKEDON today to get 10% off your first month. PrizePicks Go to PrizePicks.com/lockedonnfl and use code lockedonnfl for a first deposit match up to $100! Gametime Download the Gametime app, create an account, and use code LOCKEDON for $20 off your first purchase. LinkedIn LinkedIn Jobs helps you find the qualified candidates you want to talk to, faster. Post your job for free at LinkedIn.com/LOCKEDONNFL. Terms and conditions apply. FanDuel Right now, NEW customers get ONE HUNDRED AND FIFTY in BONUS BETS – GUARANTEED when you place a FIVE DOLLAR BET. Visit FanDuel.com/LOCKEDON to get started. FANDUEL DISCLAIMER: 21+ in select states. First online real money wager only. Bonus issued as nonwithdrawable free bets that expires in 14 days. Restrictions apply. See terms at sportsbook.fanduel.com. Gambling Problem? Call 1-800-GAMBLER or visit FanDuel.com/RG (CO, IA, MD, MI, NJ, PA, IL, VA, WV), 1-800-NEXT-STEP or text NEXTSTEP to 53342 (AZ), 1-888-789-7777 or visit ccpg.org/chat (CT), 1-800-9-WITH-IT (IN), 1-800-522-4700 (WY, KS) or visit ksgamblinghelp.com (KS), 1-877-770-STOP (LA), 1-877-8-HOPENY or text HOPENY (467369) (NY), TN REDLINE 1-800-889-9789 (TN) Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Cincinnati Bengals' coaching staff will look different in 2024. Will that lead to changes on offense for Zac Taylor, Joe Burrow and company? The guys answer that question, plus they talk about Tee Higgins' future, what the Bengals could do to address holes at running back, tight end and more!Join the Locked On Bengals Subtext Community! https://joinsubtext.com/lockedonbengalsFind and follow Locked On Bengals on your favorite podcast platforms:Apple Podcasts: https://podcasts.apple.com/us/podcast/locked-on-bengals-daily-podcast-on-the-cincinnati-bengals/id1159723162Spotify: https://open.spotify.com/show/7AObc0lh0WmQl5fJVgtajsGoogle Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vbG9ja2Vkb25iZW5nYWxz?sa=X&ved=0CAYQrrcFahcKEwio_sXtj8nuAhUAAAAAHQAAAAAQAgStitcher: https://www.stitcher.com/show/locked-on-bengalsSupport Us By Supporting Our Sponsors!Jase MedicalEmpower yourself when you purchase a Jase Case, providing you with a personal supply of 5 antibiotics that treat 50+ infections. Get yours today at jasemedical.com and use code LOCKEDON to get $20 off your order.eBay MotorsFor parts that fit, head to eBay Motors and look for the green check. Stay in the game with eBay Guaranteed Fit at eBayMotos.com. Let's ride. eBay Guaranteed Fit only available to US customers. Eligible items only. Exclusions apply.BetterHelpThis episode is sponsored by BetterHelp. Make your brain your friend, with BetterHelp. Visit BetterHelp.com/LOCKEDON today to get 10% off your first month.PrizePicksGo to PrizePicks.com/lockedonnfl and use code lockedonnfl for a first deposit match up to $100!GametimeDownload the Gametime app, create an account, and use code LOCKEDON for $20 off your first purchase.LinkedInLinkedIn Jobs helps you find the qualified candidates you want to talk to, faster. Post your job for free at LinkedIn.com/LOCKEDONNFL. Terms and conditions apply.FanDuelRight now, NEW customers get ONE HUNDRED AND FIFTY in BONUS BETS – GUARANTEED when you place a FIVE DOLLAR BET. Visit FanDuel.com/LOCKEDON to get started.FANDUEL DISCLAIMER: 21+ in select states. First online real money wager only. Bonus issued as nonwithdrawable free bets that expires in 14 days. Restrictions apply. See terms at sportsbook.fanduel.com. Gambling Problem? Call 1-800-GAMBLER or visit FanDuel.com/RG (CO, IA, MD, MI, NJ, PA, IL, VA, WV), 1-800-NEXT-STEP or text NEXTSTEP to 53342 (AZ), 1-888-789-7777 or visit ccpg.org/chat (CT), 1-800-9-WITH-IT (IN), 1-800-522-4700 (WY, KS) or visit ksgamblinghelp.com (KS), 1-877-770-STOP (LA), 1-877-8-HOPENY or text HOPENY (467369) (NY), TN REDLINE 1-800-889-9789 (TN) Learn more about your ad choices. Visit podcastchoices.com/adchoices

What is creatine, and does it really live up to the hype? Are there other benefits of creatine supplementation other than muscle growth? This episode's guest is Dr. Darren Candow, a scientific advisor, consultant, speaker, and university professor at the University of Regina. Dr. Candow's internationally renowned research program primarily focuses on creatine and developing exercise and nutritional intervention strategies for improving aging musculoskeletal health and function.In this episode, Dr. Candow and I discuss:- What creatine is, and why it's important- Reasons everybody should take creatine- The most effective dosing strategies for creatine- How the body and the brain respond to creatine supplementation- Creatine for stroke recovery, cognitive decline, and stronger bonesThe NACC course has certified over 500 coaches now. This is the state of the art human performance coaching company lead by a team of experts. Learn more about the NACC: https://www.neuroathletics.com.au/naccWant to ask me a question? You can ask me anything I have covered on this podcast, go to : https://dexa.ai/louisa[00:00] Introduction[01:20] Did You Know the Brain Produces Its Own Creatine?[04:08] The History of Creatine Research [07:38] Why Everybody Should Be Supplementing with Creatine[12:41] Creatine as a Protective Mechanism For Concussions[18:48] The Potential Role of Creatine in Stroke Recovery[22:46] Can Creatine Help Improve Cognitive Decline?[26:45] Early Research on Creatine and Depression[28:00] Creatine For Bone Strength[32:13] Dosing Strategy: Creatine For Bones, Brain, and Muscles[33:32] Creatine and Female Fertility[38:50] The Three Most Popular Dosing Strategies For Creatine[44:05] Parting Thoughts Links and Resources:Darren on Instagram: https://www.instagram.com/dr.darrencandow/Dr. Candow on Twitter: https://twitter.com/darrencandowFind Dr. Candow's research here: Darren Candow - Google ScholarThe Neuro Athletics Newsletter Instagram: louisanicola_Twitter : louisanicola_YouTube: Louisa Nicola